Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine

by Célia Dupain, Anne Catherine Harttrampf, Giorgia Urbinati, Birgit Geoerger, Liliane Massaad-Massade
Published 2017-03-01

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer.

by Giorgia Urbinati, Hafiz Muhammad Ali, Quentin Rousseau, Hubert Chapuis, Didier Desmaële, Patrick Couvreur, Liliane Massaad-Massade
Published 2015-01-01

Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigations.

by Hafiz Muhammad Ali, Giorgia Urbinati, Hubert Chapuis, Didier Desmaele, Jean-Rémi Bertrand, Patrick Couvreur, Liliane Massaad-Massade
Published 2014-01-01

Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide

by Giorgia Urbinati, Isabelle de Waziers, Mateja Slamiç, Tobias Foussignière, Hafiz M Ali, Didier Desmaële, Patrick Couvreur, Liliane Massaad-Massade
Published 2016-01-01

Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A

by Suzan Boutary, Marie Caillaud, Mévidette El Madani, Jean-Michel Vallat, Julien Loisel-Duwattez, Alice Rouyer, Laurence Richard, Céline Gracia, Giorgia Urbinati, Didier Desmaële, Andoni Echaniz-Laguna, David Adams, Patrick Couvreur, Michael Schumacher, Charbel Massaad, Liliane Massaad-Massade
Published 2021-03-01